Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Sep;26(9):973-4.
doi: 10.1038/cr.2016.96. Epub 2016 Aug 12.

Closing the gap: astrocytes and brain metastasis

Affiliations
Comment

Closing the gap: astrocytes and brain metastasis

Gino B Ferraro et al. Cell Res. 2016 Sep.

Abstract

Astrocytes are emerging as essential regulators of brain metastasis progression. In a current issue of Nature, Chen et al. identify a novel mechanism of astrocyte-carcinoma interaction and exploit vulnerabilities therein to slow brain metastatic growth in pre-clinical models.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Astrocytes impact both early and late stage brain metastasis progression. Circulating tumor cells producing ST6GALNAC5 bypass the BBB and seed the brain parenchyma. Tumor L1CAM and SERPIN expression is required for colonization and expansion in the brain. This sequence of events suggests that the astrocyte response selects for cancer cells with the best survival potential in the brain microenvironment. Chen et al.'s findings reveal that enduring cancer cells in turn instruct astrocytes to promote survival signaling.

Comment on

References

    1. Chen Q, Boire A, Jin X, et al. Nature 2016; 533:493–498. - PMC - PubMed
    1. Kodack DP, Askoxylakis V, Ferraro GB, et al. Cancer Cell 2015; 27:163–175. - PMC - PubMed
    1. Bos PD, Zhang XH, Nadal C, et al. Nature 2009; 459:1005–1009. - PMC - PubMed
    1. Kienast Y, von Baumgarten L, Fuhrmann M, et al. Nat Med 2010; 16:116–122. - PubMed
    1. Valiente M, Obenauf AC, Jin X, et al. Cell 2014; 156:1002–1016. - PMC - PubMed

Substances